Intercept Pharmaceuticals | ICPT - DEBITO



DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
Amgen USD 57.32B 2.72B 2026-03
Arrowhead Research USD 983.69M 5.77M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 8.09B 1.53B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Moderna USD 1.3B 7M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Novartis USD 49.01B 2.02B 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06